Dec 07, 2016 13:00 pm UTC| Business
MALVERN, Pa., Dec. 07, 2016 -- Aclaris Therapeutics, Inc. (Nasdaq:ACRS), today announced that its Investigational New Drug (IND) Application for ATI-50001, an orally administered investigational Janus Kinase (JAK)...
Neos Therapeutics to Present at BMO Prescription for Success Healthcare Conference
Dec 07, 2016 13:00 pm UTC| Business
DALLAS/FORT WORTH, Texas, Dec. 07, 2016 -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing and commercializing innovative extended-release (XR) products for the treatment of...
Dec 07, 2016 13:00 pm UTC| Business
NEWARK, Calif., Dec. 07, 2016 -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company developing therapies to treat indications with high unmet medical need, today announced the...
Vera Bradley Announces Fiscal Third Quarter 2017 Results
Dec 07, 2016 13:00 pm UTC| Business
Third quarter net revenues totaled $126.7 million, flat with last year Third quarter net income totaled $8.8 million, or $0.24 per diluted share (including a $0.04 per share income tax benefit related to the release of...
Dec 07, 2016 13:00 pm UTC| Business
INDIANAPOLIS, Dec. 07, 2016 -- The Finish Line, Inc. (NASDAQ:FINL) today announced the following webcast: What:Third Quarter Fiscal 2017 Financial Results Conference CallWhen:Wednesday, December 21, 2016 at 8:30 a.m....
Dec 07, 2016 13:00 pm UTC| Business
AUSTIN, Texas, Dec. 07, 2016 -- XBiotech Inc. (NASDAQ:XBIT), developer of True Human™ therapeutic antibodies, today announced that enrollment has been completed in its randomized, double-blind, placebo-controlled Phase...
Dec 07, 2016 13:00 pm UTC| Business
AUSTIN, Texas, Dec. 07, 2016 -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat genetic rare diseases...